1. The document discusses when to call an immunologist in an interstitial lung disease (ILD) clinic. It provides information on clinical signs, autoantibodies, and instrumental exams that can help recognize autoimmune ILD associated with rheumatic diseases. 2. Risk factors for developing ILD in autoimmune rheumatic diseases include certain diseases like systemic sclerosis, as well as specific autoantibodies. Monitoring of pulmonary symptoms depends on the underlying rheumatic disease but may include regular testing and imaging. 3. A multidisciplinary approach is important for diagnosing and managing autoimmune ILD, and guidelines recommend evaluating any newly diagnosed ILD for an underlying autoimmune rheumatic disease.